HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma

被引:71
作者
Zubovits, J
Buzney, E
Yu, L
Duncan, LM [1 ]
机构
[1] Massachusetts Gen Hosp, Dermatopathol Unit WRN 820, Boston, MA 02114 USA
[2] Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Pathol, Toronto, ON, Canada
[3] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Univ Western Australia, Nedlands, WA 6009, Australia
关键词
melan-a; MART-1; S-100; HMB-45; NK1/C3; immunohistochemistry; melanoma;
D O I
10.1016/j.humpath.2003.09.019
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The diagnosis of melanoma metastatic to lymph node remains a difficult problem given its histological diversity. We examined the staining patterns of S-100, NK1/C3, HMB45, and MART-1 (DC10) in melanoma metastases to lymph nodes. Immunohistochemical stains were performed on tissue sections of 126 formalin-fixed lymph nodes from 126 patients with an established diagnosis of metastatic melanoma. A total of 98% of cases (123 of 126) stained positive for S-100, 93% (117 of 125) stained positive for NK1/C3, 82% (103 of 126) stained positive for MART-1, and 76% (95 of 125) stained positive for HMB45. The distribution and intensity of staining varied among these markers. A diffuse staining pattern, defined as >50% of tumor cells stained, was observed in 83% of MART-1-positive cases but in only 56% of S-100-positive cases, 48% of NK1/C3-positive cases, and 34% of HMB-45-positive cases. A maximally intense signal was almost always observed for MART-1 (83% of positive cases) but was rarely observed for NK1/C3 (20%). S-100 and HMB45 showed maximally intense staining in 50% and 54% of cases, respectively. S-100 aid NK1/C3 stained both histiocytes and melanocytes, whereas MART-1 and HMB45 stained only melanocytes. Seventy-eight cases (63%) stained positive for all 4 markers, 17 cases (14%) stained for A markers except HMB-45, 13 cases (10%) stained for all markers except MART-1, 6 cases (5%) stained only with S-100 and NK1/C3, 4 cases (3%) stained only with S-100 and HMB-45, and 2 cases stained for all markers except S-100. One case each stained for the following: only S-100, only S-100 and HMB-45, and all markers except NK1/C3. One case exhibited absence of staining for any of these markers. We demonstrate that lymph node metastases of melanoma are heterogeneous with regard to tumor marker expression. S-100 and NK1/C3 were the most sensitive stains for detecting metastatic melanoma; however, they both also stain other nontumor cells in lymph nodes. MART-1 did not stain histiocytes and exhibited a more frequently intense and diffuse staining pattern than NK1/C3. HMB45 was less sensitive and demonstrated less diffuse staining than MART-1.
引用
收藏
页码:217 / 223
页数:7
相关论文
共 36 条
[1]  
ANWAR F, 2000, AM J CLIN PATHOL, V114, P629
[2]   HMB-45 immunohistochemical staining of sentinel lymph nodes - A specific method for enhancing detection of micrometastases in patients with melanoma [J].
Baisden, BL ;
Askin, FB ;
Lange, JR ;
Westra, WH .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (08) :1140-1146
[3]   A comparative immunohistochemical study of MART-1 expression in Spitz nevi, ordinary melanocytic nevi, and malignant melanomas [J].
Bergman, R ;
Azzam, H ;
Sprecher, E ;
Manov, L ;
Munichor, M ;
Friedman-Birnbaum, R ;
Ben-Itzhak, O .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (03) :496-500
[4]   Immunoreactivity for A103, an antibody to Melan-A (MART-1), in adrenocortical and other steroid tumors [J].
Busam, KJ ;
Iversen, K ;
Coplan, KA ;
Old, LJ ;
Stockert, E ;
Chen, YT ;
McGregor, D ;
Jungbluth, A .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (01) :57-63
[5]   Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas [J].
Chen, YT ;
Stockert, E ;
Jungbluth, A ;
Tsang, SL ;
Coplan, KA ;
Scanlan, MJ ;
Old, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :5915-5919
[6]   The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A) [J].
Clarkson, KS ;
Sturdgess, IC ;
Molyneux, AJ .
JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (03) :196-200
[7]   OCCULT TUMOR-CELLS IN THE LYMPH-NODES OF PATIENTS WITH PATHOLOGICAL STAGE-I MALIGNANT-MELANOMA - AN IMMUNOHISTOLOGICAL STUDY [J].
COCHRAN, AJ ;
WEN, DR ;
MORTON, DL .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1988, 12 (08) :612-618
[8]   Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A, and gp100 in metastatic melanoma lesions: Implications for immunotherapy [J].
Cormier, JN ;
Abati, A ;
Fetsch, P ;
Hijazi, YM ;
Rosenberg, SA ;
Marincola, FM ;
Topalian, SL .
JOURNAL OF IMMUNOTHERAPY, 1998, 21 (01) :27-31
[9]  
Cormier JN, 1998, INT J CANCER, V75, P517, DOI 10.1002/(SICI)1097-0215(19980209)75:4<517::AID-IJC5>3.0.CO
[10]  
2-W